Abstract Purpose To compare MMC 0.002% efficacy in preventing haze after PRK in relation
to MMC 0.02%. Patients and methods We conducted a prospective study with patients with …

Background To study the effect of prophylactic application of mitomycin-C on haze formation
in photorefractive keratectomy (PRK) for high myopia. Methods Fifty-four eyes of 28 myopic …

OBJECTIVE: To determine whether the duration of mitomycin C (MMC) 0.02% application
affects visual outcome or the incidence of subepithelial haze in patients undergoing …

Purpose: To study the effect of prophylactic application of mitomycin-C on regression and
corneal haze formation after photorefractive keratectomy (PRK) for high myopia. Methods …

Background: This study aimed to compare two doses of Mitomycin C in reducing haze
formation after photorefractive keratectomy. Methods: 170 eyes of 85 patients enrolled; in …

Purpose To evaluate the safety and efficacy of mitomycin-C (MMC) 0.01%(0.1 mg/mL) in
preventing haze formation after wavefront-guided photorefractive keratectomy (PRK) for …

Purpose To evaluate the anti‐haze effect and visual outcome after intraoperative mitomycin
C (MMC) use during photorefractive keratectomy (PRK) in myopia or myopic astigmatism …

Purpose: To evaluate the outcome of primary or retreatment photorefractive keratectomy
(PRK) or photo-therapeutic keratectomy (PTK) with mitomycin C (MMC) 0.02% applied …

ABSTRACT PURPOSE: To evaluate the safety and efficacy of phototherapeutic keratectomy
(PTK) with single application of mitomycin C for patients with severe corneal haze following …

ABSTRACT PURPOSE: To evaluate the efficacy, safety, and predictability of therapeutic
scraping and application of a diluted 0.02% mitomycin C solution to treat haze and …